- Home
- NRSN vs EEA Comparison
NRSN vs EEA Comparison
Compare NRSN & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- EEA
- Stock Information
- Founded
- NRSN 2017
- EEA 1986
- Country
- NRSN Israel
- EEA Germany
- Employees
- NRSN N/A
- EEA N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- EEA Trusts Except Educational Religious and Charitable
- Sector
- NRSN Health Care
- EEA Finance
- Exchange
- NRSN Nasdaq
- EEA Nasdaq
- Market Cap
- NRSN 58.8M
- EEA 66.7M
- IPO Year
- NRSN 2021
- EEA N/A
- Fundamental
- Price
- NRSN $1.91
- EEA $10.18
- Analyst Decision
- NRSN Buy
- EEA
- Analyst Count
- NRSN 2
- EEA 0
- Target Price
- NRSN $14.00
- EEA N/A
- AVG Volume (30 Days)
- NRSN 442.8K
- EEA 9.2K
- Earning Date
- NRSN 07-11-2025
- EEA 01-01-0001
- Dividend Yield
- NRSN N/A
- EEA 1.92%
- EPS Growth
- NRSN N/A
- EEA N/A
- EPS
- NRSN N/A
- EEA N/A
- Revenue
- NRSN N/A
- EEA N/A
- Revenue This Year
- NRSN N/A
- EEA N/A
- Revenue Next Year
- NRSN N/A
- EEA N/A
- P/E Ratio
- NRSN N/A
- EEA N/A
- Revenue Growth
- NRSN N/A
- EEA N/A
- 52 Week Low
- NRSN $0.51
- EEA $7.45
- 52 Week High
- NRSN $2.60
- EEA $9.26
- Technical
- Relative Strength Index (RSI)
- NRSN 51.18
- EEA 62.88
- Support Level
- NRSN $2.04
- EEA $9.85
- Resistance Level
- NRSN $2.35
- EEA $10.18
- Average True Range (ATR)
- NRSN 0.25
- EEA 0.12
- MACD
- NRSN -0.04
- EEA -0.01
- Stochastic Oscillator
- NRSN 28.74
- EEA 71.36
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.